JUMP-C: A randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients

10.1002/hep.26275 ◽

2013 ◽

Vol 58 (2) ◽

pp. 514-523 ◽

Author(s):

Paul J. Pockros ◽

Donald Jensen ◽

Naoky Tsai ◽

Ryan Taylor ◽

Alnoor Ramji ◽

...

Keyword(s):

Randomized Trial ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Pegylated Interferon Alpha ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

Faculty Opinions recommendation of JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976572.793470828 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Randomized Trial ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Pegylated Interferon Alpha ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

430 INITIAL PK/PD ANALYSIS OF HIGH-DOSE NON-PEGYLATED INTERFERON ALPHA-2B ADMINISTERED BY CONTINUOUS SUBCUTANEOUS INFUSION TO THERAPY-NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1

Journal of Hepatology ◽

10.1016/s0168-8278(11)60432-7 ◽

2011 ◽

Vol 54 ◽

pp. S174-S175

Author(s):

E.A. Grovender ◽

J. Lande ◽

S. Mische ◽

B. Van Antwerp

Keyword(s):

Interferon Alpha ◽

Pegylated Interferon ◽

High Dose ◽

Pegylated Interferon Alpha ◽

Subcutaneous Infusion ◽

Hcv Genotype ◽

Interferon Alpha 2B ◽

Continuous Subcutaneous Infusion ◽

Download Full-text

Su1060 Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naïve Patients: Pooled Analysis of Phase III Studies

Gastroenterology ◽

10.1016/s0016-5085(14)63551-4 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-977

Author(s):

Tarik Asselah ◽

Donald M. Jensen ◽

Graham Foster ◽

Mark Sulkowski ◽

Denis Ouzan ◽

...

Keyword(s):

Pegylated Interferon ◽

Pooled Analysis ◽

Phase Iii ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Phase Iii Studies

Download Full-text

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

Annals of Hepatology ◽

10.5604/16652681.1198803 ◽

2016 ◽

Vol 15 (3) ◽

pp. 333-349 ◽

Author(s):

Donald M. Jensen ◽

Tarik Asselah ◽

Douglas Dieterich ◽

Graham R. Foster ◽

Mark S. Sulkowski ◽

...

Keyword(s):

Pegylated Interferon ◽

Pooled Analysis ◽

Phase 3 ◽

Two Phase ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

Su1053 Virological Response in Treatment-Naïve Patients With Chronic HCV Genotype-1 Infection Receiving Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin Is Unaffected by Ribavirin Dose Reduction

Gastroenterology ◽

10.1016/s0016-5085(14)63544-7 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-975-S-976 ◽

Author(s):

Tarik Asselah ◽

Donald M. Jensen ◽

Graham Foster ◽

Mark Sulkowski ◽

Denis Ouzan ◽

...

Keyword(s):

Dose Reduction ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Α ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Download Full-text

1210 ABT-267 COMBINED WITH PEGYLATED INTERFERON ALPHA-2A/RIBAVIRIN IN GENOTYPE 1 (GT1) HCV-INFECTED TREATMENT-NAIVE SUBJECTS: 12 WEEK ANTIVIRAL AND SAFETY ANALYSIS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61222-7 ◽

2012 ◽

Vol 56 ◽

pp. S480 ◽

Author(s):

G.J. Sullivan ◽

M. Rodriques-Torres ◽

E. Lawitz ◽

F. Poordad ◽

M. Kapoor ◽

...

Keyword(s):

Interferon Alpha ◽

Pegylated Interferon ◽

Safety Analysis ◽

Pegylated Interferon Alpha ◽

Treatment Naïve

Download Full-text

1206 ABT-072 OR ABT-333 COMBINED WITH PEGYLATED INTERFERON/RIBAVIRIN AFTER 3-DAY MONOTHERAPY IN HCV GENOTYPE 1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS: 12-WEEK SUSTAINED VIROLOGIC RESPONSE (SVR12) AND SAFETY RESULTS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61218-5 ◽

2012 ◽

Vol 56 ◽

pp. S478 ◽

Author(s):

F. Poordad ◽

E. Lawitz ◽

E. DeJesus ◽

K.V. Kowdley ◽

I. Gaultier ◽

...

Keyword(s):

Sustained Virologic Response ◽

Pegylated Interferon ◽

Virologic Response ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

P724 VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION

Journal of Hepatology ◽

10.1016/s0168-8278(14)60886-2 ◽

2014 ◽

Vol 60 (1) ◽

pp. S311

Author(s):

T. Asselah ◽

D.M. Jensen ◽

G.R. Foster ◽

M.S. Sulkowski ◽

D. Ouzan ◽

...

Keyword(s):

Dose Reduction ◽

Virological Response ◽

Pegylated Interferon ◽

Hcv Genotype ◽

Treatment Naïve ◽

Hcv Genotype 1 ◽

Download Full-text

Faculty Opinions recommendation of PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976477.793470825 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Randomized Trial ◽

Hcv Genotype ◽

Treatment Naïve ◽

Download Full-text

P1129 EFFECT OF HCV GENOTYPE-1 SUBTYPE ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: POOLED DATA FROM PHASE III TRIALS

Journal of Hepatology ◽

10.1016/s0168-8278(14)61289-7 ◽

2014 ◽

Vol 60 (1) ◽

pp. S457

Author(s):

I.M. Jacobson ◽

D.M. Jensen ◽

D. Dieterich ◽

C. Sarrazin ◽

G.R. Foster ◽

...

Keyword(s):

Pegylated Interferon ◽

Phase Iii ◽

Hcv Genotype ◽

Pooled Data ◽

Phase Iii Trials ◽

Treatment Naïve ◽

Download Full-text